Mapping the Pan-cancer Somatic Mutation Burden Across 27 Malignancies

Inside the nucleus, a silent accumulation of errors dictates the fate of a cell. These genetic typos are the hidden architects of malignancy, yet their distribution across different organs has remained largely unpredictable.

Identifying shared patterns across diverse cancers allows clinicians to target the root causes of disease rather than just the location of the tumour. This early-stage research, currently awaiting peer review, seeks to define these universal signatures by looking at the scale of the problem.

The Architecture of Pan-cancer Somatic Mutation Burden

The researchers analysed 10,008 samples across 27 cancer types, identifying 1,930 driver genes with a high frequency of errors. By examining data from whole-exome and whole-genome sequencing, the team found:

• 960 mutation hotspots, including 578 regions not previously recorded in the COSMIC database.
• Six low-burden genes, such as ECRG4 and SEPTIN11, which appear significant across at least five malignancies.
• Analysis of 400,000 single cells showing consistent gene suppression in immune cells and activation in endothelial cells.

These preliminary results suggest that genes like DOCK3 and TEAD2 carry previously overlooked mutation clusters. If validated, these hotspots could provide new targets for drug development and help clinicians organise patients into more precise treatment groups based on their genetic profile.